Home/Pipeline/Recombinant Human Papillomavirus (HPV) Vaccine (Cecolin®)

Recombinant Human Papillomavirus (HPV) Vaccine (Cecolin®)

Prevention of cervical cancer (HPV 16/18)

ApprovedCommercial

Key Facts

Indication
Prevention of cervical cancer (HPV 16/18)
Phase
Approved
Status
Commercial
Company

About Zhifei Biological Products

Zhifei Biological Products is a major force in China's vaccine industry, with a mission to develop and provide high-quality, accessible vaccines to prevent infectious diseases. Its key achievements include the successful commercialization of a recombinant human papillomavirus (HPV) vaccine, a recombinant COVID-19 vaccine, and a portfolio of other preventive vaccines. The company's strategic direction focuses on leveraging its R&D and manufacturing capabilities to expand its product pipeline and solidify its domestic leadership while exploring international opportunities.

View full company profile